BNET Industries

Pfizer Inc.

(PFE) is in the Pharma Industry

Market Cap:$150.4B
Last Fiscal Year Sales:$48.4B
  • Public
  • US
Dow Jones Description

Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.

Number of Employees 81,800
Contact Information

235 E 42nd St

New York, New York 10017-5755

www.pfizer.com

(212) 573-2323

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Pfizer and B.C. launch $9M collaboration to tackle cancer

    12/03/09 - Joint Venture / Alliance - View Story

  • Reportlinker Adds Growth Factors Blood And Tissue - A World Report

    12/02/09 - Joint Venture / Alliance - View Story

  • Barclays appoints US lev loan syndicate head - memo

    12/02/09 - Merger / Acquisition - View Story

  • Pfizer signs agreement with Protalix BioTherapeutics for Taliglucerase alfa

    12/02/09 - Joint Venture / Alliance - View Story

  • Pfizer Inc. PFE JOBS Acquires Rights to Protalix Biotherapeutics's Gaucher Drug in Deal Worth $115M

    12/02/09 - Joint Venture / Alliance - View Story

  • Roche's Merger Formula for Genentech

    11/30/09 - Merger / Acquisition - View Story

  • Pfizer PFE Will Not Renew Ethical Distribution Agreement Term with MWI Veterinary Supply MWIV

    11/24/09 - Joint Venture / Alliance - View Story

  • Pfizer Inc. and Wyeth; Analysis of Agreement Containing Consent Order To Aid Public Comment and...

    11/27/09 - Financial Announcement - View Story

  • A 2nd Loss for Pfizer in Drug Suits

    11/23/09 - Legal Settlement - View Story

  • Pfizer acquires stem cell therapies assets of Axordia

    11/23/09 - Merger / Acquisition - View Story

  • Standpoint Raised Its FY10 Price Target on Pfizer PFE to $24

    11/23/09 - Bond / Stock Rating - View Story

  • ImmunoVaccine signs exclusive licence deal with Pfizer

    11/23/09 - Joint Venture / Alliance - View Story

  • Pfizer Animal Health selects Bader Rutter as agency of record

    11/17/09 - Licensing / Contract - View Story

  • FDA panel backs Pfizer's anti-infection vaccine for kids

    11/19/09 - Merger / Acquisition - View Story

  • Cash Just Kept On Piling Up, But It Looks Like The Spending Has Started

    11/16/09 - Joint Venture / Alliance - View Story

  • Goldman Sachs Said Pfizer PFE Best Positioned US Pharma in China

    11/16/09 - Bond / Stock Rating - View Story

  • EDITORIAL: Difficult mix of business, science

    11/24/09 - Merger / Acquisition - View Story

  • $75M verdict unsealed in Prempro-cancer case

    11/27/09 - Merger / Acquisition - View Story

  • Sanofi-Aventis on hunt for Boston partners

    11/11/09 - Merger / Acquisition - View Story

News & Analysis

earnings and pfizer inc. and pharmaceutical company - All News and Analysis

advertisement
     PFE $18.64 -0.10 (-0.53% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 53,249,200
Shares Outstanding 8.07B
Market Cap 150.4B
Year High 18.99
Year Low 11.68
Earnings Per Share 1.20
P/E Ratio 15.53
Dividend 0.64
Yield 3.43
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement